Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.
2.

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, Zhou T, Schmidt SD, Wu L, Xu L, Longo NS, McKee K, O'Dell S, Louder MK, Wycuff DL, Feng Y, Nason M, Doria-Rose N, Connors M, Kwong PD, Roederer M, Wyatt RT, Nabel GJ, Mascola JR.

Science. 2010 Aug 13;329(5993):856-61. doi: 10.1126/science.1187659. Epub 2010 Jul 8.

3.

Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys.

Permar SR, Wilks AB, Ehlinger EP, Kang HH, Mahlokozera T, Coffey RT, Carville A, Letvin NL, Seaman MS.

J Virol. 2010 Aug;84(16):8209-18. doi: 10.1128/JVI.00656-10. Epub 2010 Jun 2.

4.

The role of antibodies in HIV vaccines.

Mascola JR, Montefiori DC.

Annu Rev Immunol. 2010;28:413-44. doi: 10.1146/annurev-immunol-030409-101256. Review.

PMID:
20192810
5.

Fc receptor-mediated antiviral antibodies.

Forthal DN, Moog C.

Curr Opin HIV AIDS. 2009 Sep;4(5):388-93. doi: 10.1097/COH.0b013e32832f0a89. Review.

6.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

7.

Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.

Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, Jost S, Cohen K, Walker B, Alter G.

J Virol. 2009 Sep;83(17):8705-12. doi: 10.1128/JVI.02666-08. Epub 2009 Jun 24.

8.

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, Haynes BF, Delfraissy JF.

AIDS. 2009 May 15;23(8):897-906. doi: 10.1097/QAD.0b013e328329f97d.

9.

Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys.

Permar SR, Kang HH, Carville A, Mansfield KG, Gelman RS, Rao SS, Whitney JB, Letvin NL.

J Immunol. 2008 Sep 1;181(5):3643-50.

10.

Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Stratov I, Chung A, Kent SJ.

J Virol. 2008 Jun;82(11):5450-9. doi: 10.1128/JVI.01952-07. Epub 2008 Mar 19.

11.

Fc receptor but not complement binding is important in antibody protection against HIV.

Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR.

Nature. 2007 Sep 6;449(7158):101-4.

PMID:
17805298
12.

Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection.

Sun Y, Permar SR, Buzby AP, Letvin NL.

J Virol. 2007 Aug;81(15):8009-15. Epub 2007 May 23.

13.

CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.

Grzywacz B, Kataria N, Verneris MR.

Leukemia. 2007 Feb;21(2):356-9; author reply 359. No abstract available.

PMID:
17251901
14.

IgG Fc receptor III homologues in nonhuman primate species: genetic characterization and ligand interactions.

Rogers KA, Scinicariello F, Attanasio R.

J Immunol. 2006 Sep 15;177(6):3848-56.

15.
16.

Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.

Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, Aubertin AM, Moog C.

J Virol. 2006 Jun;80(12):6177-81.

17.

Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.

Holl V, Peressin M, Schmidt S, Decoville T, Zolla-Pazner S, Aubertin AM, Moog C.

Blood. 2006 Jun 1;107(11):4466-74. Epub 2006 Feb 9.

18.

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

Gómez-Román VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M.

J Immunol Methods. 2006 Jan 20;308(1-2):53-67. Epub 2005 Nov 28.

PMID:
16343526
19.

NK cells in HIV infection: paradigm for protection or targets for ambush.

Fauci AS, Mavilio D, Kottilil S.

Nat Rev Immunol. 2005 Nov;5(11):835-43. Review. Erratum in: Nat Rev Immunol. 2005 Dec;5(12):969.

PMID:
16239902

Supplemental Content

Support Center